Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $101000.0.

  • Bioventus' Asset Writedowns and Impairment fell 9502.71% to $101000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 8997.08%. This contributed to the annual value of $36.4 million for FY2024, which is 5375.31% down from last year.
  • Latest data reveals that Bioventus reported Asset Writedowns and Impairment of $101000.0 as of Q3 2025, which was down 9502.71% from $193000.0 recorded in Q2 2025.
  • In the past 5 years, Bioventus' Asset Writedowns and Impairment registered a high of $124.7 million during Q4 2022, and its lowest value of -$1.3 million during Q3 2023.
  • Over the past 5 years, Bioventus' median Asset Writedowns and Impairment value was $901000.0 (recorded in 2022), while the average stood at $14.4 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first crashed by 18885.3% in 2021, then surged by 5632398.19% in 2022.
  • Bioventus' Asset Writedowns and Impairment (Quarter) stood at $7.2 million in 2021, then soared by 43.23% to $10.3 million in 2022, then plummeted by 112.98% to -$1.3 million in 2023, then skyrocketed by 283.97% to $2.5 million in 2024, then tumbled by 95.89% to $101000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $101000.0 for Q3 2025, versus $193000.0 for Q2 2025 and $650000.0 for Q1 2025.